Summers, Rufolo & Rodgers
Call For A Free Consultation
423-933-2738
View Our Practice Areas

Defective Drugs Archives

Weight loss drug Belviq pulled from market for cancer risk

Recently, the U.S. Food and Drug Administration asked the Japanese drug maker Eisai Inc. to pull its weight loss drug Belviq from the market due to concerns the drug can slightly increase the user's risk of cancer. The extended release version of the drug is also being pulled. Eisai issued a statement saying it withdrew the drug voluntarily but disagrees with the FDA's interpretation of the data. It said it still believes Belviq has benefits that outweigh the risk.

Addicted to Purdue Pharma opioids? June 30 deadline for claims

People injured by their opioids can file personal injury claims directly against Purdue Pharma, the manufacturer of the painkillers OxyContin, MS Contin and Ryzolt. Purdue is in bankruptcy, and part of that process involves divvying up the company's assets among creditors and claimants.

California may declare acetaminophen a known human carcinogen

Acetaminophen is one of the most common over-the-counter drugs in the world. It is known by the brand names Tylenol and Excedrin, and it is found in many OTC remedies for pain, flu and fever. It has been available without a prescription in the U.S. since 1955. Now, the State of California is considering labeling it a known human carcinogen.

Warning: Gabapentin with opioids can cause breathing problems

The U.S. Food and Drug Administration has ordered manufacturers to include warnings on the product labels for gabapentinoids, certain drugs that depress the central nervous system, and opioids. The warning will indicate that taking gabapentinoids with opioids can cause serious breathing problems. These problems were also found in people taking gabapentin who had underlying respiratory problems like COPD.

FDA: Dollar Tree over-the-counter topicals may be adulterated

The U.S. Food and Drug Administration has sent a warning letter to Dollar Tree stores notifying the company that certain over-the-counter medications sourced from Shanghai and other international cities may be defective. The FDA detected flaws at several facilities between 2017 and 2019 and notified both the manufacturers and Dollar Tree that these products may be adulterated. Nevertheless, Dollar Tree continued to receive medications from those manufacturers in violation of the Federal Food Drug and Cosmetic Act.

Did Johnson & Johnson's subsidiary market opioids deceptively?

In September, a judge in Oklahoma ruled that Johnson & Johnson's subsidiary, Janssen Pharmaceuticals, caused a public nuisance with its two opioid medications, Duragesic and Nucynta. He also ruled that the company had marketed these drugs deceptively. The Judge ordered J&J and Janssen to pay $572 million in damages to the State.

Jury imposes $8 billion punitive damages against J&J for Risperdal

Thousands of lawsuits involving the drug Risperdal have been filed against Johnson & Johnson and its subsidiary Janssen Pharmaceuticals, Inc. The main complaint by most of the young men suing is that taking Risperdal caused gynecomastia, or the abnormal development of breasts. Many plaintiffs were prescribed Risperdal as minors and none were told they might develop breasts.

Without admitting fault, J&J reaches opioid deal with 2 counties

According to the Centers for Disease Control and Prevention, Ohio had the second-highest rate of fatal opioid overdoses in the country in 2017. West Virginia led the nation in per capita opioid deaths. That's part of the reason why Ohio is central to the National Prescription Opiate Litigation, where thousands of cases against opioid manufacturers have been consolidated.

Email Us For A Response

Free Consultation

Bold labels are required.

Contact Information
disclaimer.

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.

close

Privacy Policy

Summers, Rufolo & Rodgers
735 Broad Street, Suite 800
Chattanooga, TN 37402-2913

Toll Free: 888-778-6575
Phone: 423-933-2738
Fax: 423-266-5211
Chattanooga Law Office Map

Review Us
735 Broad Street, Suite 800